Join the club for FREE to access the whole archive and other member benefits.

GlaxoSmithKline and Google to develop bioelectronic medicines


Key points from article :

Glaxo and Verily Life Sciences LLC, formerly Google Life Sciences, create Galvani Bioelectronics with $714 million budget.

Many biological processes are controlled by electrical signals transmitted from the nervous system to the body’s organs.

Distortions of signaling pathways involved in long-term diseases including diabetes, asthma and arthritis.

Treatments would work by attaching miniature electronic devices to individual nerves.

Mentioned in this article:

Tap on icon for description, click on resource name for more details.


Company developing life changing neuromodulation therapies for patients with chronic disease.


Research and develop pharmaceutical medicines, vaccines and consumer healthcare products


Research organization devoted to the study of life sciences.